A school-age child diagnosed with depression is receiving antidepressant therapy. The nurse would instruct the parents to notify the physician immediately if the child demonstrates which of the following?
A) Loss of interest
B) Gastric upset
C) Sedation
D) Urinary retention
A
Response:
Children taking antidepressants are at risk for the development of presuicidal behavior, which may be indicated by a loss of interest or pleasure. Gastric upset, sedation, and urinary retention may or may not occur, but none of these would be as important to report as the potential for self-harm.
You might also like to view...
A prescriber has ordered deferasirox [Exjade] to treat iron overload associated with chronic blood transfusions. The nurse learns that the patient takes cholestyramine to reduce cholesterol
The nurse will contact the provider to request an order to: a. increase the cholestyramine dose. b. increase the deferasirox dose. c. monitor cholesterol levels. d. monitor liver function tests.
Nurses can find guidance for an ethical response to war in professional codes. Directives in these codes include all of the following except:
a. respect life and human dignity. b. advocate for prevention of conflict. c. always adhere to governmental policies. d. provide equitable care for all victims.
A physician orders 100 mg of chlorpromazine (Thorazine?) twice daily and 2 mg of benztropine (Cogentin?) twice daily as needed for a client with paranoid schizophrenia
The nurse understands that the purpose for chlorpromazine (Thorazine?) is to: A) Ensure that the client can get enough sleep. B) Reduce psychotic symptoms. C) Increase levels of dopamine in the brain. D) Prevent extrapyramidal symptoms.
The nurse is coordinating a clinical research trial with pediatric clients. From which clients should the nurse seek assent to participate in the research? Select all that apply
1. A 9-year-old client who qualifies to test a medication for muscular dystrophy 2. A precocious 4-year-old starting as a participant in a cystic fibrosis research study 3. A 10-year-old starting in an investigative study for clients with precocious puberty 4. A 7-year-old client with leukemia who has elected to receive a newly developed trial medication 5. A 13-year-old client beginning participation in a research program for attention deficit/hyperactivity disorder (ADHD) treatments